# Serina Therapeutics, Inc.: Form 8-K, filed Nov 13, 2025

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2025-11-13
- Accepted by EDGAR: Nov 13, 2025, 06:05 ET
- Period: 2025-11-13
- Accession: 0001708599-25-000135
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000135/ser-20251113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000135/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000170859925000135/ser-20251113.htm

Filed Nov 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001708599-25-000135. Last ingested by Listed: Nov 3, 2026, 18:22 ET. No prices; not investment advice.